Author Information
Christopher J. H. Porter is affiliated with the Drug Delivery, Disposition and Dynamics division at the Monash Institute of Pharmaceutical Sciences, Monash University, located in Parkville, Victoria, Australia. He is also associated with the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology at Monash University.Research Contributions
Christopher J. H. Porter has made significant contributions to the field of nanotechnology and drug delivery systems. His research primarily focuses on enhancing the oral bioavailability of drugs through innovative formulation strategies, including the use of lipid-based formulations and prodrugs. His work has explored the promotion of lymphatic transport to improve drug absorption and systemic exposure, particularly for lipophilic drugs. Some of his notable studies include enhancing the oral delivery of buprenorphine, stabilizing lipophilic ionic liquid salts, and targeting the delivery of mycophenolic acid to the mesenteric lymph node. His research has broad implications for improving the efficacy and safety of orally administered medications.Aliases
Christopher J. H. Porter is known by several aliases, including Christopher J H Porter, Christopher Jh Porter, C. J. H. Porter, Christopher J. H. Porter, C J H Porter, Chris Porter, Christopher J.h. Porter, and C J Porter.Publication and Citation Metrics
| Metric |
Value |
| Number of Papers |
299 |
| Citation Count |
20665 |
| H-index |
73 |
